← BIIB Overview
8-KApril 29, 20264/29/26
BIIB — 8-K Filing
Track for AlertsBIIB 8-K Summary
On April 29, 2026, BIOGEN INC. filed an 8-K covering Financial Statements and Exhibits (Item 9.01) and Results of Operations and Financial Condition (Item 2.02). Primary disclosure: (d) ExhibitsThe exhibits listed below are furnished as part of this Current Report on Form 8-K.Exhibit No.Description99.1Biogen's press release dated April 29, 2026104Cover Page Interactive Data File (embedded within the Inline XBRL document)SIGNATURESPursuant to the requirements…
8-K Items Disclosed
Item 2.02 — Results of Operations and Financial Condition
Quarterly or annual earnings results released. Often paired with a press release as Exhibit 99.1.
of this Current Report on Form 8-K and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that Section, nor shall such document be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.
Item 9.01 — Financial Statements and Exhibits
Press releases, exhibits, and supporting documents attached to this filing.
(d) ExhibitsThe exhibits listed below are furnished as part of this Current Report on Form 8-K.Exhibit No.Description99.1Biogen's press release dated April 29, 2026104Cover Page Interactive Data File (embedded within the Inline XBRL document)SIGNATURESPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIOGEN INC.By: /s/ Wendell Taylor Wendell TaylorSecretary Date: April 29, 2026
Structured financials are not available for this filing. View the original on SEC EDGAR for details.
Current DredgeCap Risk Profile
3.2/10
MODERATE RISK
Dilution Risk
LOW2.0/10
Liquidity Risk
LOW2.0/10
Debt Toxicity
LOW2.5/10
Profitability Risk
MODERATE3.5/10
Going Concern✓ Not flagged
The risk profile above reflects the latest cached DredgeCap analysis for BIIB. For the full filing-by-filing analyst report (red flags, primary risk driver, what moves the stock), open BIIB's company page.
What is a 8-K?
A current report disclosing a material event that occurred between regular reporting periods. Companies are required to file an 8-K within four business days of certain events including earnings releases, executive changes, acquisitions, debt obligations, restructurings, and material agreements. Each 8-K specifies one or more 'Items' identifying which event triggered the filing.
Form-type explainers and 8-K item descriptions are derived from SEC documentation. Financial values are extracted from SEC-tagged XBRL — see the "Source filings" list above each table for direct EDGAR links to every cited filing. This page does not constitute investment advice. Always consult the original filing on SEC EDGAR for authoritative content, and consult a licensed financial advisor for investment decisions.